BENITIONSClinical Trial Intelligence

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

不适用 已完成 NCT04227379

适应症Diabetes Mellitus, Type 2
分期不适用
申办方VA Office of Research and Development
状态已完成
受试者人数366 人
干预(药物)Intervention 1- DSMS+, Comparison - DSMS
开始日期2023年1月30日
完成日期2025年4月30日
结果公布日2026年6月1日

摘要

One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.

Change in HbA1c Percent Time in Control

pre-enrollment, 6 month follow up · percent (%) of time in control

DSMS23.41 ± 34.96 percent (%) of time in control
DSMS+ (DSMS Plus)21.61 ± 40.55 percent (%) of time in control
p-value.6519
Mean Difference (Net)1.80 (95% CI -6.05–9.65)

Change in HbA1c

pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin

DSMS-0.36 ± 1.37 Percentage of glycosylated hemoglobin
DSMS+ (DSMS Plus)-0.40 ± 1.29 Percentage of glycosylated hemoglobin
p-value.7552
Mean Difference (Net).05 (95% CI -.25–.34)

在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文

同一适应症的其他试验

全部试验

本页整理自 ClinicalTrials.gov 的公开数据,不构成医疗建议,也不构成投资建议。请务必咨询专业医师。